DLL4 and neoplasm: In the tumor setting the same mechanism operates so that Dll4 or Notch1 inhibition drives extreme angiogenic sprouting, which generates non-functional vasculature, in turn leading to inhibited tumor growth [19], [20], [21], [22], [23], reviewed in [24].